Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

zalcitabine

A synthetic dideoxynucleoside. After intracellular phosphorylation to its active metabolite, zalcitabine preferentially inhibits the gamma form of DNA polymerase present in tumor cell mitochondria, resulting in the inhibition of tumor cell mitochondrial DNA replication and tumor cell death.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	dideoxycytidine
US brand name:	Hivid
Abbreviation:	ddC
Chemical structure:	2',3'-dideoxycytidine
IND number:	28975 30858 33134
NSC code:	606170

zalcitabine

Search NCI's Drug Dictionary